Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1992-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.36.12.2808PMID 1482150PMCID PMC245550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fusion assays monitoring intermixing of aqueous contents.

  1993cited by this paper
• Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment.

  1991cited by this paper
• Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

  1991cited by this paper
• Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.

  1991cited by this paper
• Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice.

  1991cited by this paper
• Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages.

  1991cited by this paper
• Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: freeze fracture analysis of infected mouse liver

  1991cited by this paper
• Potential toxicity of ciprofloxacin.

  1991cited by this paper
• Study on hepatotoxicity and other side-effects of antituberculosis drugs.

  1990cited by this paper
• Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.

  1990cited by this paper
• Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.

  1989cited by this paper
• Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

  1989cited by this paper
• Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

  1989cited by this paper
• Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice

  1989cited by this paper
• Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice

  1988cited by this paper
• Susceptibility of Mycobacterium avium complex to various two-drug combinations of antituberculosis agents.

  1988cited by this paper
• Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

  1987cited by this paper
• Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents

  1987cited by this paper
• Synergistic effects of antimycobacterial drag combinations onMycobacterium avium complex determined radiometrically in liquid medium

  1987cited by this paper
• Liposomes as Drug Carriers to Liver Macrophages: Fundamental and Therapeutic Aspects

  1986cited by this paper
• Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

  1986cited by this paper
• Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare

  1986cited by this paper
• The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival.

  1986cited by this paper
• Targeting of Drugs With Synthetic Systems

  1985cited by this paper
• Treatment of infections in patients with the acquired immunodeficiency syndrome.

  1985cited by this paper
• Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes

  1985cited by this paper
• Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice.

  1985cited by this paper
• In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

  1984cited by this paper
• Interaction of liposomes with Kupffer cells in vitro.

  1984cited by this paper
• Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

  1981cited by this paper
• Post-column derivatization of guanidino compounds in high-performance liquid chromatography using ninhydrin.

  1981cited by this paper
• Multiple DrugResistance inMycobacterium avium: Isthe WallArchitecture Responsible fortheExclusion of Antimicrobial Agents?

  1981cited by this paper
• Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes.

  1980cited by this paper
• Separation of leukocytes from blood and bone marrow. Introduction.

  1968cited by this paper
• The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

  1968cited by this paper
• Phosphorus assay in column chromatography.

  1959cited by this paper

• Advances in drug delivery systems for intracellular infections: minimizing antibiotic dependency.

  2026cites this paper
• Oleanolic acid-taxifolin self-assembled nanoparticles for effective treatment of S. aureus infections by inhibiting its internalization and reproduction.

  2025cites this paper
• Exploring the Therapeutic Potential of Antibiotics in Hyperglycemia-Induced Macrophage Dysfunctions

  2025cites this paper
• Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections

  2025cites this paper
• ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation

  2021cites this paper
• On the formulation of pH-sensitive liposomes with long On the formulation of pH-sensitive liposomes with long circulation times circulation times

  2021cites this paper
• Stress impact of liposomes loaded with ciprofloxacin on the expression level of MepA and NorB efflux pumps of methicillin-resistant Staphylococcus aureus

  2021cites this paper
• Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections.

  2021cites this paper
• Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research

  2020cites this paper
• Mycobacterium Avium Infection

  2020influential citation
• Bioinspired Liposomes for Oral Delivery of Colistin to Combat Intracellular Infections by Salmonella enterica

  2019cites this paper
• Bacteria-Targeting Nanoparticles with Microenvironment-Responsive Antibiotic Release To Eliminate Intracellular Staphylococcus aureus and Associated Infection.

  2018cites this paper
• Highlights in Endocytosis of Nanostructured Systems.

  2017cites this paper
• Gr upSM The Potential of Nanotechnology for Tuberculosis Treatment

  2016cites this paper
• Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies

  2016cites this paper
• NANOTECHNOLOGY FOR PERIODONTAL DISEASE

  2015cites this paper
• Lipid- and polymer-based drug delivery carriers for eradicating microbial biofilms causing medical device-related infections.

  2015cites this paper
• Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems.

  2015cites this paper
• Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.

  2014cites this paper
• Nanoparticle approaches against bacterial infections.

  2014cites this paper
• Damar İçi Yolla Verilen Serbest ve Lipozomal Ampisilinin Kan Farmakokinetik Profillerinin Karşilaştirilmasi

  2014cites this paper
• Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.

  2014cites this paper
• Preparation of Biocompatible Carboxymethyl Chitosan Nanoparticles for Delivery of Antibiotic Drug

  2013cites this paper
• Studies on the interaction mechanism of aminopyrene derivatives with human tumor-related DNA.

  2013cites this paper
• Prevention and treatment of biofilms by hybrid- and nanotechnologies

  2013cites this paper
• Studies on the Interaction Mechanism of Pyrene Derivatives with Human Tumor-Related DNA

  2012cites this paper
• Study of ocular drug delivery system using drug-loaded liposomes

  2011cites this paper
• Liposomes:Formulation and characterisation as contrast agents and as vaccine delivery systems

  2011cites this paper
• Liposomes as Drug Delivery Carriers to Biofilms

  2010cites this paper
• Drug delivery systems for potential treatment of intracellular bacterial infections.

  2010cites this paper
• Drug-Encapsulating EGF-Sensitive Liposomes for EGF-Overexpressing Cancer Therapies

  2009cites this paper
• The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.

  2008cites this paper
• Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections

  2007cites this paper
• Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?

  2005cites this paper
• Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro.

  2005cites this paper
• Molecular insights into aminoglycoside action and resistance.

  2005cites this paper
• Liposome-encapsulated antibiotics.

  2005cites this paper
• Synergistic Effect of Phospholipid-Based Liposomes and Propylthiouracil on U-937 Cell Growth

  2005cites this paper
• COMPARATIVE PHARMACOKINETICS OF FREE AND LIPOSOME-ENCAPSULATED AMPICILLIN AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATIONS

  2004cites this paper
• Intracellular Visualization of Ampicillin-Loaded Nanoparticles in Peritoneal Macrophages Infected in Vitro with Salmonella typhimurium

  2004cites this paper
• Development of a Liposome Formulation of Ethambutol

  2004cites this paper
• Chapter 17 – Mycobacterial Disease in Patients with HIV Infection

  2004cites this paper
• Does ciprofloxacin interact with neutral bilayers? An aspect related to its antimicrobial activity.

  2003cites this paper
• Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.

  2003cites this paper
• Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis

  2003cites this paper
• Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages.

  2003cites this paper
• Versatility of Aminoglycosides and Prospects for Their Future

  2003cites this paper
• Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposome-encapsulated enrofloxacin in rabbits.

  2002cites this paper
• Ciprofloxacin in Polyethylene Glycol-Coated Liposomes: Efficacy in Rat Models of Acute or Chronic Pseudomonas aeruginosa Infection

  2002cites this paper
• Ciprofloxacin-loaded bovine serum albumin microspheres: preparation and drug-release in vitro.

  2001cites this paper
• Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.

  2001cites this paper
• Liposomal targeting of antimicrobial agents to bacterial infections

  2001cites this paper
• Improved Efficacy of Ciprofloxacin Administered in Polyethylene Glycol-Coated Liposomes for Treatment of Klebsiella pneumoniae Pneumonia in Rats

  2001cites this paper
• Effects of Liposome-Encapsulated Ciprofloxacin on Phagocytosis, Nitric Oxide and Intracellular Killing of Staphylococcus Aureus by Murine Macrophages

  2000cites this paper
• Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.

  2000cites this paper
• Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish Shepherd Dog neutrophils in vitro

  2000cites this paper
• Experimental Intravitreal Application of Ciprofloxacin in Rabbits

  1999cites this paper
• The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages.

  1999cites this paper
• Rationale for and Efficacy of Prolonged-Interval Treatment Using Liposome-Encapsulated Amikacin in Experimental Mycobacterium avium Infection

  1998cites this paper
• Treatment of human immunodeficiency virus, Mycobacterium avium and Mycobacterium tuberculosis infections by liposome-encapsulated drugs**This chapter is dedicated to the memories of my father Professor Orhan Düzgüneş, and my father-in-law Professor John Flasher.

  1998cites this paper
• 6-Fluoroquinolone–liposome interactions: fluorescence quenching study using iodide

  1998cites this paper
• Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: pharmacokinetics and in vitro antimicrobial activity

  1998cites this paper
• Glaskörper-Clearance von liposomeninkorporiertem Ciprofloxacin nach intravitrealer Injektion

  1998cites this paper
• Antibacterial Efficacy against an In Vivo Salmonella typhimurium Infection Model and Pharmacokinetics of a Liposomal Ciprofloxacin Formulation

  1998cites this paper
• [Clearance of liposome-incorporated ciprofloxacin after intravitreal injection in rabbit eyes].

  1998cites this paper
• Expression of the partition coefficients of a homologous series of 6-fluoroquinolones

  1997cites this paper
• Impact of Mycobacterium Avium Infection on Macrophage-Liposome Interaction

  1997cites this paper
• Ciproflexacin-loaded polyisobutylcyanoacrylate nanoparticles: Preparation and characterization

  1997cites this paper
• Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease.

  1997cites this paper
• Protective effect of liposomal gentamicin against systemic acute murine brucellosis.

  1997cites this paper
• Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

  1997cites this paper
• Mycobacterium avium Complex Infection

  1997cites this paper
• Liposomes as Carriers of Antimicrobial Drugs

  1997cites this paper
• Characterization of ciprofloxacin liposomes: derivative ultraviolet spectrophotometric determinations.

  1997cites this paper
• Characterization of a mannosylphospholipid liposome system for drug targeting to alveolar macrophages

  1997cites this paper
• Cellular Retention of Liposome-Delivered Anionic Compounds Modulated by a Probenecid-Sensitive Anion Transporter

  1997cites this paper
• Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin

  1996cites this paper
• Influence of physicochemical properties of fluoroquinolones on encapsulation efficiency in liposomes

  1996cites this paper
• Evidence of Segregation of a Quinolone Antibiotic in Dipalmitoylphosphatidylcholine Environment

  1996cites this paper
• Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection model.

  1996cites this paper
• Liposomal Aerosols in the Management of Pulmonary Infections

  1996cites this paper
• Liposomes in the Treatment of Parasitic, Viral, Fungal and Bacterial Infections

  1995cites this paper
• Liposome-mediated therapy of human immunodeficiency virus type-1 and mycobacterium infections

  1995cites this paper
• Delivery of antimicrobials to infected tissue macrophages

  1995cites this paper
• Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection

  1995cites this paper
• Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes

  1995cites this paper
• Fluoroquinolone distribution in a phospholipid environment studied by spectrofluorimetry

  1994cites this paper
• Use of liposome preparation to treat mycobacterial infections.

  1994cites this paper
• Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres.

  1994cites this paper
• Treatment and developmental therapeutics of Mycobacterium avium complex (MAC) infections.

  1994cites this paper
• Contributions of animal and macrophage models to the understanding of host parasite interaction of Mycobacterium avium complex (MAC) disease.

  1994cites this paper
• Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophages.

  1994cites this paper
• In-vitro activities of quinolones against mycobacteria.

  1993cites this paper
• Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis

  1993cites this paper